Pharma News Archive

Pharma News: June 2007

June 1	Bristol-Myers Squibb Awards Immunicon New Research Services Agreement for Oncology Biomarker Development
June 1	Mylan Wins Omeprazole Patent Litigation
June 1	Jazz Pharmaceuticals, Inc. Announces Initial Public Offering
June 1	Nventa Consolidates Offices Into San Diego
June 1	Black Horse Capital Opposes the Strategic Direction of Cypress Bioscience
June 1	MOLOGEN AG Sells Spanish Subsidiary
June 1	Isogenica Enters into Research and License Agreement with Wyeth
June 1	Revision - Decision Fails Patients with Transfusion-Dependent Anemia
June 1	Termination of Development of Fixed Dose Combination Product of Actos + TAK-536
June 1	AstraZeneca’s Prilosec Patents Upheld By Court
June 1	Barr Confirms Decision in Azithromycin Inventorship Suit
June 1	Pharmaceutical Blog Chatter Continues About Dr. Steven Nissen’s Avandia Revelations, Most Bloggers Refute
June 1	Transition Therapeutics Acquires All Remaining Shares of NeuroMedix Inc.
June 1	ImpaxX Announces Decision on Generic Prilosec Litigation
June 4	Bayer Schering Pharma AG Will Terminate Registration With the U.S. SEC
June 4	Final Data from a Phase 2 Trial Presented at ASCO Specifies Dose-dependent Activity of Adecatumumab (MT201)
June 4	AstraZeneca Acquires Biologics Manufacturing Facility in Canada
June 4	Cell Genesys and Medarex Report Follow-Up Data From a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
June 4	New Data Evaluating Sutent, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
June 4	Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
June 4	GlaxoSmithKline Reports Positive New Data on Tykerb at the 2007 ASCO Annual Meeting
June 4	Phase III Ixabepilone Study Demonstrated Significant Improvement in Progression-Free Survival in Patients With Advanced Metastatic Breast Cancer
June 4	Telik Announces Top-Line Results of TELCYTA ASSIST-2 Trial
June 4	Telik Reports Results of TELCYTA ASSIST-1 Trial
June 4	Telik Reports Results of TELCYTA Assist-3 Trial
June 4	Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac Weekly
June 4	DTC Advertising Improvements Observed In Two New Reports
June 4	FDA Announces New Advisory Committee to Address Risk Communication
June 5	Neurogen Announces Continuing Preclinical and Clinical Development Work and Conclusion of Research Component of Collaboration for Investigational Pain Drug
June 5	APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
June 5	Eurand and GSK Reach Development Milestone
June 5	Telik Announces Clinical Hold on TELCYTA Trials
June 5	Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
June 5	Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
June 5	Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
June 5	Valeant Pharmaceuticals Agrees to Sell Manufacturing Facilities in Basel, Switzerland and Humacao, Puerto Rico
June 5	Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.
June 5	Mylan Wins Its Amlodipine Case With Pfizer
June 6	CRO Company Merger; A First for China's Drug Development Contract Research Organization Industry
June 6	GlaxoSmithKline Response to New England Journal of Medicine Editorials
June 6	VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
June 6	AstraZeneca CFO to Join Goldman Sachs
June 6	WaferGen Completes Merger and Private Placement of $10.7 Million
June 6	Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
June 6	Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
June 6	Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
June 7	American Diabetes Association Strongly Advises Patients Using Rosiglitazone to See Their Doctor
June 7	Takeda Revises Actos (pioglitazone HCl) Prescribing Label
June 7	Roche Recalls Viracept Due to Chemical Impurity
June 7	Agilent Technologies Adds Strength to Its Life Science Business With Acquisition of Stratagene
June 7	Intertek Acquires QTI Laboratory
June 7	Forbion Announces Successful Exit from Alantos Pharmaceuticals
June 7	Genzyme to Build New Biomanufacturing Plant to Support Growth of Thymoglobulin
June 7	Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa Patents
June 8	Radiant Research Acquired by New Ownership Group
June 8	Schering-Plough and Bayer Healthcare Announce Availability of ZETIA in Japan, the First Cholesterol-Lowering Agent With a Novel Mechanism of Action Approved in Japan in 18 Years
June 8	Johnson & Johnson Highlights Growth Strategies for Pharmaceutical and Consumer Businesses
June 8	On the Launch and Measures for Proper Use of the Anti-Cancer Agent Avastin
June 8	Renovis Announces Achievement of Milestones in VR1 Collaboration with Pfizer Inc.
June 8	Pharma Blogs This Week: Hot & Heavy Congressional Committee Hearings, DTC Study Shows No Effect on Pricing, and Another Pharma CFO Bites the Dust
June 8	FDA Science Board to Meet on June 14
June 11	ZARS, Inc. Files Registration Statement for Initial Public Offering
June 11	Announcement of the Launch of the Selective COX-2 Inhibitor Celecox Tablets in Japan
June 11	Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
June 11	Archemix and Merck KGaA Sign Strategic Alliance
June 11	AMRI Receives Milestone Payment From Licensing Agreement with Bristol-Myers Squibb
June 11	Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
June 11	Merck Signs Strategic Alliance With Archemix
June 11	Pediatric Inhaled Corticosteroid Asthma Medication Features New Dose Counters to Help Track Usage
June 11	Barr Announces Withdrawal of Zyprexa Zydis Patent Litigation
June 11	Teva Receives Favorable Court Decision Regarding Generic Lotrel; Novartis' Motion for Preliminary Injunction Denied
June 11	US Court Allows Teva to Resume US Sales of Its Generic Version of Lotrel
June 11	Athersys Raises $65 Million in Concurrent Reverse Merger and Private Equity Offering
June 11	U.S. Department of Justice Investigation of Bristol-Myers Squibb in Proposed Plavix Patent Settlement Is Resolved
June 12	alli - The OTC Weight Loss Product - On Shelves Nationwide Later This Week
June 12	Vical Receives $6 Million Grant From NIH to Advance RapidResponse DNA Vaccine Platform
June 12	BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
June 12	Kissei and Eisai sign a License Agreement to Develop and Commercialize Glufast, A Rapid-acting Insulin Secretagogue in 10 Asian Countries
June 12	China Biopharma Signed LOI to Acquire All the Interest of a Chinese Regional Pharmaceutical Distribution Company
June 12	Artes Medical Forms New Subsidiary to Commercially Develop and License Medical Applications of Its Microsphere Technology
June 12	Repligen Reports Ruling on Sanctions Motion Against ImClone
June 13	Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
June 13	New Survey Shows Product Liability Litigation May Jeopardize Treatment Outcomes for People with Severe Mental Illnesses
June 13	American Oriental Bioengineering Enters Into a Letter-of-Intent to Acquire Established Plant Based Pharmaceutical Company
June 13	Reps. Hinchey & Stupak: FDA's Bond With Drug Industry Is As Strong As Ever
June 13	Accentia Biopharmaceuticals' Majority-Owned Subsidiary, Biovest, Receives Request From the Independent Data Monitoring Committee to Conduct Interim Analysis of Anti-Cancer Vaccine, BiovaxID
June 13	Health Care Plans and Consumer Groups Unite and Call on Legislature to Pass Rx Gift Disclosure Law
June 14	Interpublic Announces Development in SEC Investigation
June 14	Charles River Laboratories Completes Chinese Joint Venture
June 14	Canadian Levofloxacin Patent Upheld by Federal Appeal Court
June 14	Cordis Corporation Resolves Corporate Warning Letter
June 18	NicOx Provides an Update on NCX 4016
June 18	Geron Increases Stake in TA Therapeutics Joint Venture
June 18	FDA Converts Telcyta Full Clinical Hold to Partial Hold
June 18	GlaxoSmithKline Expects to Launch Up to Five Major New Medicines for Oncology in Next Three Years
June 18	Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy
June 18	Nabi Biopharmaceuticals Announces Creation of Biologics Business Unit & Provides Strategic Updates
June 18	Merck & Co. Ordered to Pay Attorneys' Fees, Costs Following Vioxx Consumer Fraud Finding
June 18	The Public is Doubtful that Strengthening the FDA's Oversight of the Prescription Drug Industry Will Make a Difference
June 19	Roche Acquires NimbleGen to Gain Entry Into High-Growth Research Microarrray Market
June 19	Bayer Raises Guidance for 2007 and 2009
June 19	Verispan Reports: Biotech Companies Cut Sales Forces, but Managed Care Execs Want More Contact
June 19	Diamyd Continues Invalidated Study
June 19	Regulatory Cooperation Expanded
June 19	ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
June 19	Safety Measures for Oseltamivir Phosphate and Chugai's Future Approach
June 19	Impax Announces Lawsuit Related to Generic Version of Depakote ER
June 19	Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
June 19	Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
June 19	Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
June 19	CuraGen to Close Pilot Manufacturing Plant
June 20	Shire In-Licenses Juvista (Human TGFbeta3) From Renovo
June 20	Heygood, Orr, Reyes & Bartolomei: $5.5 Million Award in First Federal Fentanyl Patch Trial
June 20	New Potential Treatment in Development for Patients Facing Heart Health Challenges
June 20	Proteros biostructures Announce Successful Achievement of Milestone in Fragment-Based Protein Crystallography Collaboration
June 20	Texas Family Sues GlaxoSmithKline (GSK) Over Man's Heart Attack Death Following Avandia Use
June 20	Pfizer Discontinues Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer
June 20	Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non Small Cell Lung Cancer
June 20	Wyeth Responds to Verdict in Diet Drug Case
June 21	Cardinal Health Completes Initial Tender Offer for VIASYS Healthcare
June 21	WHI Study of Younger Postmenopausal Women Links Estrogen Therapy to Less Plaque in Arteries
June 21	PharmalLive Releases from Pipeline to Market 2007, an Exclusive Annual Special Report
June 22	Icagen Receives Notification from McNeil of Termination of Collaboration Agreement
June 22	Viragen Streamlines Research Focus and Halts Further Development of OVA System
June 22	Paion Reduces Number of Employees
June 22	Barr Receives Approval for Generic Vesanoid Capsules, 10 mg
June 22	European Medicines Agency Agrees on Action Plan Following the Recall of Viracept and Recommends Suspension of the Marketing Authorisation
June 22	Pharma Bloggers Discuss Delay in Maraviroc Approval, Removal of Provisions in Prescription Drug User Fee Act, Triumph for Plavix Marketers, and More on Sicko
June 25	AstraZeneca Announces Symbicort Is Now Available In The U.S.
June 25	European Medicines Agency Recommends Restricted Use for Piroxicam
June 25	Biodel Inc. Announces VIAject(TM) Data at Oral Presentation at the American Diabetes Association Meeting
June 25	Apidra Improved A1C In People With Type 2 Diabetes When Added to Basal Insulin and Oral Antidiabetic Treatments (BOT)
June 25	Roche and Toyama Chemical Enter Licensing Agreement to Develop Potential Breakthrough Drug to Treat Rheumatoid Arthritis
June 25	New Data Show Patients Treated With Avandia (Rosiglitazone Maleate) Incurred Lower Medical Costs and Used Fewer Healthcare Resources When Compared to Patients Treated With Sulphonylureas
June 25	Generex Biotechnology to Initiate Phase III Clinical Trial of Generex Oral-lyn in 2007 Third Quarter
June 25	Diabetes Patients Make Significant Gains in Disease Control; Still, Nearly Half Fail to Reach ADA Treatment Goals
June 25	Coalition Urges American Medical Association to Halt Sale of Physician Data to Pharmaceutical Marketing Firms
June 25	New Findings Show Half of Americans Surveyed Importing Drugs without a Prescription
June 25	U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
June 26	Ventana Advises Shareholders to Defer Taking Any Action in Response to Roche Offer
June 26	UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for Multiple Sclerosis
June 26	Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations
June 26	Pharma ChemOutsourcing Conference Posts Attendee List for September Custom Synthesis Blockbuster Show in New Jersey
June 26	Commonly Prescribed Antidepressants Associated with Lower Bone Density in Older Men and Women
June 26	NextBio Announces License Agreement with Genzyme
June 26	Wyeth Licenses Drug Targets from Osteoporosis Collaboration with Galapagos
June 26	Abbott and Genentech Announce Global, Integrated Research, Development and Commercialization Collaboration in Oncology
June 26	Daiichi Sankyo Commences Patent Litigation Against Mylan in the United States
June 26	Organon Announces Acquisition of Kadmus Pharmaceuticals' FAAH Inhibitor Technology
June 26	Pharsight Invited to Present on Oncology Modeling and Simulation at AAPS National Biotechnology Conference on June 28, 2007
June 26	Biotechnology Council of New Jersey and Pennsylvania Bio to Host Seventh Annual Biosciences Symposium
June 26	Amgen Submits Testimony to House Ways & Means Committee
June 26	First Consulting Group Acquires Zorch, Inc.
June 26	Clinquest Takes Stake in Enceladus
June 26	Physicians Favor a DTC Moratorium More Strongly Than Consumers, though Both Groups Cite Public Safety as the Key Benefit, according to New TNS Healthcare Research
June 27	inVentiv Health to Acquire AWAC, Leader in Providing Medical Cost Containment Services to Payors
June 27	inVentiv Health to Acquire Chandler Chicco Agency
June 27	Vermont Attorney General Sorrell Releases Pharmaceutical Company Report
June 27	Cardinal Health Reaffirms Fiscal 2008 Outlook; Raises Long-Term Profit Goals
June 27	Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
June 27	Vasogen Reports on Outcome of FDA Meeting
June 27	FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
June 27	Biogen Idec Announces Preliminary Results of Its Modified ''Dutch Auction'' Tender Offer
June 27	Roche Commences Tender Offer for Ventana for $75 Per Share in Cash
June 27	Update on Migenix Agreement with Schering-Plough for Hepatitis C Virus Treatment
June 27	VASTox Announces Significant Progress in Pharmaceutical Services Business
June 27	Guideline and Med Ad News Host Panel to Discuss Issues Surrounding Patient Compliance
June 27	MichBio Announces Its 2007 Expo; Bio CEO to be Keynote Speaker
June 27	Spherix Signs Definitive Agreement for Sale of Information Subsidiary
June 28	Pharsight Preferred Stockholders Elect to Convert Preferred Shares Into Common Stock
June 28	Materia Licenses Metathesis Catalyst Platform to Eisai
June 28	Pfizer Board of Directors to Initiate Face-to-Face Meetings with Company's Institutional Investors on Corporate Governance Policies and Practices
June 28	Isotechnika Will Be Represented at the Canadian Dermatology Annual Conference
June 28	Bespak plc Exubera Update
June 28	The General Public Supports Breaking Drug Patents To Ensure Access To HIV/AIDS Drugs In Poorer Countries
June 28	Lawmakers Praise Committee Passage of Biologics Legislation
June 28	Bioscience Leaders Discuss Strategies to Propel Industry, Innovations Throughout Southern California
June 28	Cardinal Health Completes Subsequent Tender Offer for VIASYS Healthcare
June 28	Thallion Announces Sale of Majority Stake in Caprion Proteomics to Great Point Partners
June 29	Genmab Regains Rights to HuMax-CD4
June 29	Lorus Therapeutics Announces Receipt of Court Approval for Proposed Plan of Arrangement
June 29	Prescription Access Litigation: Federal Judge Allows Zyprexa Class Action to Go Forward
June 29	Urigen N.A., Inc. Completes Shareholder Meeting
June 29	Karo Bio Announces Delay in KB5359 Development
June 29	Yet Another Pfizer Whistleblower Comes Forth Through Blogs, CME Criticism Continues, and Dr. Rost Gains Access to Astrazeneca Ethics Violation Website
June 29	The International Society for Medical Publication Professionals (ISMPP) Publishes Position Paper on the Role of the Professional Medical Writer
June 29	Combination of Sartorius Biotech Division and Stedim Completed
June 29	Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer
June 29	RAPS Holds Japan Seminar, High-Ranking Officials Participate

Pharma News Archive

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources

Pharma News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals

	A to Z Drug List	Drugs by Condition	Pill Identifier	Drug Interactions Checker	Medical Encyclopedia	Medical Dictionary	Pharmaceutical News & Articles	Community Forums
Welcome Guest\|Register or Sign In My Viewing History \| My Drug List \| My Interactions Lists \| Member Offers